Cargando...
An independently validated nomogram for isocitrate dehydrogenase-wild-type glioblastoma patient survival
BACKGROUND: In 2016, the World Health Organization reclassified the definition of glioblastoma (GBM), dividing these tumors into isocitrate dehydrogenase (IDH)-wild-type and IDH-mutant GBM, where the vast majority of GBMs are IDH-wild-type. Nomograms are useful tools for individualized estimation of...
Guardado en:
| Publicado en: | Neurooncol Adv |
|---|---|
| Autores principales: | , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Oxford University Press
2019
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6777501/ https://ncbi.nlm.nih.gov/pubmed/31608326 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/noajnl/vdz007 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|